Back to 
UBS Group AG
UBS Group AG
AIDX1 quarters
Position history for UBS Group AG's holdings in 20/20 BIOLABS INC
UBS Group AG holds 8,314 shares of AIDX (20/20 BIOLABS INC), worth $15,631 as of 2026-Q1. This is a new position.
Current Value
$15,631
Current Shares
8,314
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of AIDX: Cresset Asset Management, LLC, CITADEL ADVISORS LLC, XTX Topco Ltd, MAI Capital Management, Allworth Financial LP